99% Savings - Buy Just @1 Rs X
Nebilong 2.5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of High BP.
The optimal dosage of Nebilong 2.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Nebilong 2.5 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Nebilong 2.5 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Nebilong 2.5 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Nebilong 2.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Nebilong 2.5 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Other conditions have been mentioned below in the Nebilong 2.5 Tablet contraindications section.
Drug reaction of Nebilong 2.5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Nebilong 2.5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Nebilong 2.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebilong 2.5 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Nebilong. If you are pregnant, do not take Nebilong without a doctor's advice.
Is the use of Nebilong 2.5 Tablet safe during breastfeeding?
Nebilong may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Nebilong 2.5 Tablet on the Kidneys?
Nebilong rarely harms the kidneys.
What is the effect of Nebilong 2.5 Tablet on the Liver?
Side effects of Nebilong rarely affect the liver.
What is the effect of Nebilong 2.5 Tablet on the Heart?
Nebilong has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Nebilong 2.5 Tablet unless your doctor advises you to do so -
Is this Nebilong 2.5 Tablet habit forming or addictive?
Forming a habit of Nebilong 2.5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Nebilong 2.5 Tablet can make you feel drowsy.
Is it safe?
Nebilong 2.5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Nebilong 2.5 Tablet is not used to treat mental disorders.
Interaction between Food and Nebilong 2.5 Tablet
When consumed with certain foods, Nebilong 2.5 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nebilong 2.5 Tablet
Consult your doctor before consuming alcohol while taking Nebilong 2.5 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897